Clinical trial Recruiting at 1 site Interventional Ages 6 to 17

Cognitively engaging exercise to boost thinking skills in children and teens with cancer

Official title: An Investigator Initiated, Non-randomized Controlled Trial on the Effect of Cognitively Challenging Physical Activity on Executive Functions in Paediatric Cancer Patients

Run by University of Bern · NCT06839794 · Data updated 2026-11-12

This trial tests whether mentally challenging physical activity can improve thinking skills and self-control (executive functions) in children and adolescents undergoing cancer treatment.

Quick facts

Study typeInterventional
Ages6 Years to 17 Years
SexAll
Enrollment70 (estimated)
SponsorUniversity of Bern
Academic / other
Locations1 site (Bern)
StatusRecruiting
StartedMay 10, 2025
Main results expectedDecember 1, 2027
Study endsDecember 1, 2028
Registry record updatedAugust 12, 2025
Trial IDNCT06839794 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 6 to 17.99 years with any cancer diagnosis requiring at least six weeks of chemo/radiotherapy or CNS surgery who can provide consent and participate in exercise are ideal candidates.

Probably not a fit

Patients with cognitive or physical disabilities that prevent participation, those unable to follow study procedures (for example because of language barriers), or those who are medically unstable may not benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children and adolescents aged 6 to 17 receiving chemotherapy, radiotherapy, or CNS surgery will take part in a program of physically active exercises that are designed to also challenge attention, memory, and planning. Participants will follow a regimen of cognitively challenging physical activity and receive standard physical activity recommendations while researchers measure changes in executive function using cognitive tests. The intervention is delivered at the University of Bern clinical sites and requires in-person participation for supervised sessions and assessments. Outcomes will compare cognitive performance and related functional measures before and after the intervention period.

Why it matters

Potential benefit: If successful, the program could improve executive function, speed rehabilitation, and enhance quality of life for young cancer patients.

How similar studies have gone: Prior research shows physical activity improves fitness, fatigue, sleep, and quality of life in pediatric oncology, but using specifically cognitively challenging exercise to target executive functions in this population is relatively novel with limited direct evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Written informed consent of parents / legal guardian and participants, where applicable
* Diagnosis of any type of cancer requiring chemo- and/or radiotherapy, or CNS surgery, expected to last a minimum of at least 6 weeks at the time of recruitment
* Age: 6-17.99 years at time of recruitment

Exclusion Criteria:

* Cognitive and physical disabilities that prevent participation in the intervention.
* Inability to follow the procedures of the study, e.g. due to language problems.
* Enrolment of the investigator, his/her family members, employees and other dependent persons.
* Denied written informed consent from participants.

Where it's running

  • Inselspital, Universitätsspital Bern
    Bern, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.